BJMO - volume 9, issue 6, november 2015
J. Kerger MD
There were very few new interesting and no practice-changing data presented at the 2015 European Cancer Congress, compared to the ASCO Annual Meeting earlier this year. This lack of presentations is most probably due to the upcoming meeting of ESGO (European Society of Gynecologic Oncology), which was held in Nice end of October 2015.
(BELG J MED ONCOL 2015;9:225–28)
Read moreBJMO - volume 9, issue 4, august 2015
J. Kerger MD
The studies in gynaecological cancers presented at this year’s ASCO Annual Meeting, although not reporting breakthrough practice-changing results, are in line with the trend towards targeted therapies witnessed in recent years. In addition to this, several studies confirm the potential of immunotherapy in this setting.
(BELG J MED ONCOL 2015;9:149–53)
Read moreBJMO - volume 8, issue 5, november 2014
J. Kerger MD
Notwithstanding the fact that no breaking, practice-changing studies were presented in the sessions devoted to gynaecological cancers at this years’ annual ESMO meeting, the strong trend towards targeted therapies was confirmed, in accordance with the general theme of “precision medicine” at this meeting.
(BELG J MED ONCOL 2014;8(4):147–51)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
